Of note, EGFR‐mutated lung cancer cells (eg, H1650 cell) are more sensitive to TKI, and we thus evaluated whether USP35 silence would sensitize H1650 cell to GFB chemotherapy. This evidence concerns the gene EGFR and lung cancer.